Proteomic discovery of MNT as a novel interacting partner of E3 ubiquitin ligase E6AP and a key mediator of myeloid differentiation
Isha Kapoor(Central Drug Research Institute), Arun Kumar Trivedi(Central Drug Research Institute)
Cited by 19
Related Papers
Targeting BCL-2 in B-cell malignancies and overcoming therapeutic resistance
|Cell Death and Disease|2020|257
Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies
|Cell Death and Disease|2019|76
Nano‐LC based proteomic approach identifies that E6AP interacts with ENO1 and targets it for degradation in breast cancer cells
|IUBMB Life|2019|8
Ring finger protein 138 inhibits transcription factor C/EBPα protein turnover leading to differentiation arrest in acute myeloid leukemia
|Biochemical Journal|2024|3
Proteomic identification of C/EBPa multiprotein complex reveals that JNK1, an activator of C/EBPa is downregulated in patients with acute myeloid leukemia (AML)
|Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)|2006|0